SUR Antibodies

Santa Cruz Biotechnology features a diverse variety of SUR Antibodies for targeting sulfonylurea receptors. SUR Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Sulfonylurea receptors play a crucial role in regulating insulin secretion from pancreatic beta cells and are essential for glucose homeostasis. Their function is particularly significant in diabetes research, as sulfonylurea receptors are primary targets for medications used in diabetes treatment. Understanding sulfonylurea receptor mechanisms can provide insights into metabolic disorders and potential therapeutic strategies. Research focusing on SUR expression patterns helps advance knowledge about cellular signaling pathways and their role in maintaining metabolic balance. Investigating sulfonylurea receptor distribution across different tissues contributes to a better understanding of their physiological functions. Studies of SUR regulation mechanisms offer valuable insights into potential therapeutic approaches for metabolic diseases. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of sulfonylurea receptors and their impact on human health.